Post by Gubra

The Gubra team will be on the road throughout June, sharing new research across several international scientific meetings.   We will kick things off at the American Diabetes Association's Scientific Sessions 2026, where we will present our GUB-UCN2 program in a session titled “Preserving Lean Mass with GLP-1R Therapy: Preclinical Obesity Studies". In addition, we will present two posters focused on translational obesity research, highlighting novel preclinical models and the metabolic effects of next-generation incretin-based therapies. At the New Directions in Biology and Disease of Skeletal Muscle Conference, we will present new data on bimagrumab and apitegromab treatment in a mouse model of dexamethasone-induced muscle atrophy. At Endocrine Society's ENDO 2026, our team will contribute 2 posters showcasing advanced ovarian 3D imaging, AI-assisted follicle staging, and translational mouse models of reproductive disorders. We are also looking forward to The Extracellular Matrix Pharmacology Congress 2026, where we will present 7 posters and a talk covering metabolic disease, MASH, fibrosis, cardiovascular research, spatial transcriptomics, translatability biomarkers, senescence, and advanced 3D imaging applications. Will you be attending any of these meetings? Schedule a meeting with our team: https://lnkd.in/eN66jPbW #ENDO2026 #ADA2026 #ECM2026 #MuscleBiology #MetabolicDisease #MASH #Fibrosis #WomensHealth #DrugDiscovery #PreclinicalResearch